Andrew B. Gerry

Oxford Centre for Mission Studies — United Kingdom

Medicine · Health Sciences

18h-index3.6kcitations52works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(32), Immunotherapy and Immune Responses(26), Virus-based gene therapy research(7), Cancer Immunotherapy and Biomarkers(6), Multiple Myeloma Research and Treatments(5)

Publications50 total

Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeutics
Molecular Therapy Oncology·2026Open Access
687 TROCEPT A tumor targeted precision immunovirotherapy enabling αvβ6 integrin positive tumor localized expression of an immune checkpoint inhibitor following intravenous delivery
Regular and Young Investigator Award Abstracts·2025Open Access
700 αvβ6 integrin expression in carcinomas: a promising target for cancer therapy
Regular and Young Investigator Award Abstracts·2025Open Access
A high-throughput focused collimator for OAR-sparing preclinical proton FLASH studies: commissioning and validation
Physics in Medicine and Biology·2024· 1 citedOpen Access
TROCEPT: An oncolytic virus platform engineered for αvß6 integrin targeted tumor-localised expression of an immune checkpoint inhibitor following intravenous delivery.
Journal of Clinical Oncology·2024
Selection, engineering, and in vivo testing of a human leukocyte antigen–independent T-cell receptor recognizing human mesothelin
PLoS ONE·2024· 1 citedOpen Access
Technical note: A small animal irradiation platform for investigating the dependence of the FLASH effect on electron beam parameters
Medical Physics·2024· 9 citedOpen Access
897-C TROCEPT tumor-specific targeting and replication enables <i>in-tumor</i> production of immune checkpoint inhibitors following intravenous delivery
2023Open Access
Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8α
Journal of Immunotherapy·2023· 14 citedOpen Access
Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
Frontiers in Oncology·2023· 11 citedOpen Access
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors
Frontiers in Oncology·2022· 19 citedOpen Access
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer·2022· 48 citedOpen Access
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β
The Journal of Immunology·2021· 18 citedOpen Access
95 Inhibition of AKT signaling during expansion of TCR-engineered T-cells from patient leukocyte material generates SPEAR T-cells with enhanced functional potential in vitro
Regular and Young Investigator Award Abstracts·2020· 1 citedOpen Access
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
OncoImmunology·2019· 91 citedOpen Access
Abstract 2313: Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8α homodimer
Cancer Research·2019· 4 cited
Abstract 2313: Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8α homodimer
Immunology·2019· 1 cited
Abstract A002: Autologous Tcells transduced with the affinity enhanced NY-ESO-1c259TCR in patients with synovial sarcoma expressing low levels of the NY-ESO-1 antigen
Cancer Immunology Research·2019
Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer
Hepatology·2018· 51 citedOpen Access
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate
OncoImmunology·2018· 63 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Bent K. Jakobsen(22), Alan Bennett(17), Joseph P. Sanderson(13), Gwendolyn Binder-Scholl(12), Joanna E. Brewer(12), Nicholas J. Pumphrey(12), Edward A. Stadtmauer(10), Aaron P. Rapoport(10), Michael Kalos(10), Carl H. June(10), Bruce L. Levine(9), Nick Pumphrey(8), Helen K. Tayton-Martin(8), Dan T. Vogl(8), Brendan M. Weiss(8), Saul Yanovich(8), David S. Leake(8), Dominic Smethurst(7), Ashraf Badros(7), Irina Kulikovskaya(7)